UDFDA
Sun Pharma shares in focus after US FDA issues eight observations for Halol facilitySun Pharma shares will be in focus after the US FDA issued eight observations for its Halol facility following a GMP inspection. The plant ...
Biocon slips over 2% on 6 USFDA observationsUS health regulator issued six observations in Form 483 after pre-approval inspection of its insulin drug substance manufacturing facility ...
- Load More